PMID: 20609377 Maes M, Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Gaecki P, et al
doi: 10.1016/j.pnpbp.2018.05.005
Food and Drug Administration (FDA) for chronic weight management in adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) and at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol
J Clin Endocrinol Metab (2011) 96(6):185963
Baseline labs should be drawn before starting therapy, with follow-up testing at 8-12 weeks to assess response and guide dose adjustments
While we do not endorse extreme use for vanity purposes, a gentle boost in skin brightness and clarity is a welcome effect for many wellness patients